Posts Tagged ‘clinical’
Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
Baxter International Inc. (NYSE:BAX), in conjunction with DynPort Vaccine Company LLC (DVC), a CSC Company (NYSE:CSC), presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter’s Vero cell culture platform and does not contain an adjuvant or preservatives…
Dynavax Selects Clinical Candidate In Universal Flu Vaccine Program
Dynavax Technologies Corporation (NASDAQ: DVAX) announced that it has selected a clinical vaccine candidate for its novel Universal Flu program, completed key preclinical studies, and is reviewing clinical plans with the FDA in anticipation of initiating a Phase I study by mid-year…
MicroTransponder Raises $10 Million To Begin Clinical Trials Of Wireless Neurostimulation For Chronic Pain And Obtain FDA Clearance
MicroTransponder, Inc., a privately-held medical device company, has just announced a $7 Million Series B round of funding. MicroTransponder is developing a wireless neurostimulation platform for the treatment of chronic pain and other neurological indications. In addition, the Company is announcing that it has been awarded a $2…
Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) announced additional preliminary results from the recently completed Phase 2 clinical trial conducted in Perth, Australia at the University of Western Australia with Professors David Smith and Manfred Beilharz as principal investigators…
First Results In United States In 20 Years From Clinical Trials Of Smoked Cannabis
Researchers from the University of California’s Center for Medicinal Cannabis Research (CMCR) have found “reasonable evidence that cannabis is a promising treatment” for some specific, pain-related medical conditions. Their findings, presented to the California legislature and public, are included in a report available on the CMCR web site at http://www.cmcr.ucsd.edu…
Clinical Trial: Miniature Ultrasound Device Could Revolutionize Pain Relief
It looks more like an iPod than a medical tool. But the latest miniature ultrasound device created by Cornell biomedical engineering graduate student George K. Lewis could one day introduce a whole new level of home therapy for arthritis, injury and other painful ailments…
Clinical Study: Biologic Grafts Reduce Postoperative Pain While Creating A Repair As Durable As Synthetic Mesh In Treating Inguinal Hernias
Results from a clinical study led by Luca Ansaloni, M.D., showed that Cook Medical’s Biodesign Inguinal Hernia Graft causes less postoperative pain and discomfort while creating a repair as durable as synthetic mesh when used in Lichtenstein’s hernioplasty procedures…
Usual Care Often Not Consistent With Clinical Guidelines For Low Back Pain
Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals…
SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and its partner Sigma-Tau S.p.A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN? (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza monovalent vaccine, Focetria? from Novartis…
Trigemina Conducting Phase IIa Clinical Trial In Chronic Daily Headache
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from at least 15 days of headache pain per month…
Rx Drug Compare
Translator
By N2H